0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sexual Dysfunction Drugs Market Size Status and Forecast 2018 to 2025
Published Date: March 2019
|
Report Code: QYRE-Othe-06
Home | Market Reports | Health | Reproductive Health
Global Sexual Dysfunction Drugs Market Size Status and Forecast 2018 to 2025

Global Sexual Dysfunction Drugs Market Size Status and Forecast 2018 to 2025

Code: QYRE-Othe-06
Report
March 2019
107 Pages
QYResearch
Region: South America, Europe,
Description
Table of Content
Tables & Figures

This report focuses on the global Sexual Dysfunction Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Sexual Dysfunction Drugs development in United States, Europe and China.

Sexual dysfunctions include sexual disorders of men and women that can interfere with their sexual performance, leading to unsatisfied sexual intercourse. The major drugs used in this market are PDE5 inhibitors, whereas other drugs such as hormone-related and transurethral also have a presence in the market.

The sexual dysfunction oral drugs segment accounted for the majority market share during 2017 and will continue to grow during the forecast period. The increasing cases of sexual dysfunctions are driving the need for oral therapies such as 5HT1A receptor agonist. The demand for sexual dysfunction oral drugs such as ED drugs will further increase due to the rising awareness among healthcare professionals.

The demand for sexual dysfunction drugs is increasing due to the rising prevalence of chronic diseases such as prostate cancer, diabetes mellitus, and CVD. The market will continue to grow in the region in the forthcoming years due to the rise in unhealthy lifestyle habits and the increased risk of developing sexual dysfunctions among the population.

In 2017, the global Sexual Dysfunction Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2018-2025.

The key players covered in this study

Pfizer

GlaxoSmithKline

Merck

Eli Lilly

AbbVie

Bayer

Teva Pharmaceutical Industries

Takeda

Apricus Biosciences

Emotional Brain

Ivix LLX

Leadiant Biosciences

NexMed

S1 Biopharma

Vietstar Biomedical Research

Market segment by Type, the product can be split into

Oral Therapy

Intracavernosal Therapy

Hormonal Therapy

Transurethral Therapy

Market segment by Application, split into

Male

Female

Market segment by Regions/Countries, this report covers

United States

Europe

China

Japan

Southeast Asia

India

Central & South America

The study objectives of this report are:

To analyze global Sexual Dysfunction Drugs status, future forecast, growth opportunity, key market and key players.

To present the Sexual Dysfunction Drugs development in United States, Europe and China.

To strategically profile the key players and comprehensively analyze their development plan and strategies.

To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Sexual Dysfunction Drugs are as follows:

History Year: 2013-2017

Base Year: 2017

Estimated Year: 2018

Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Medical care is the effective as well as the guided design of all types of medical services to the people. Medical care generally revolves around service design such as patient’s safety, integrated care and patient-centered care. The topic of medical care also explores innovative and latest ideas on exactly how to develop a team of physicians in areas where medical leadership and qualitative improvement have been given utmost importance. Considering the significance of the medical care industry across the globe, QY Research has delivered impartial, insightful and complete research report which offers a crystal clear picture of prominent as well as niche markets in the industry.  

In an attempt to make this report an exclusive one, the expert team of analysts covered the various markets under the medical care industry in detail. Further, they have explored several market dynamics such as trends, opportunities, drivers and restraints to give a transparent view of this highly competitive industry. To arrive at market numbers, QY Research’s analysts have evaluated the available data over different parameters. Apart from this, one of the important section which is known as the competitive landscape has also been covered in the report. This section has given information about the top players functioning in the medical care industry. 

Medical care industry witnesses major growth in the United States since past few years

The significant regions such as Latin America, North America, Western and Eastern Europe, Middle East and Africa and the Asia Pacific including Japan are included in this report. Apart from this broad category of regions some of the niche countries, particularly in the Asia Pacific such as Malaysia, Indonesia, and Vietnam and in Latin America such as Mexico are evaluated in this report. The US lens on worldwide trends and opportunities for health systems and plans. De-hospitalization and self-aggregation are two prominent forces which are expected to drive the medical industry in the US. In the Asia Pacific region, the medical industry is expected to boom in China and India in the years to come. Increasing population, rising disposable income, and a growing geriatric population are some of the factors, which are responsible for the growth of the medical care industry in the Asia Pacific region.

A lucid analysis of competitive landscape in the medical industry makes QY Research’s report a unique one

As mentioned above, the competitive landscape section is the most significant section in this report and that is the reason the research analysts in QY Research has left no stone unturned while examining the various markets in the medical care industry. This section offers comprehensive information about the product overview, the overview of the company, and key financial and key developments related to that specific company.

Other prominent features of this section include SWOT analysis of selected companies. SWOT analysis helps in providing information about weaknesses and strength, threats and opportunities that are faced by the companies functioning in the medical care industry. Competitive landscape indeed an invaluable part of this report as it includes all the required information to study the key players operating in the medical care industry. A detailed analysis of leading companies’ strategies and their vision to sustain in this highly competitive industry is one of the significant features of this report. 

Segmental Analysis

The markets covered under the purview of the medical care industry are generally segmented as, by product, by application, by an end user and by region. QY Research has given emphasis on providing segmental analysis in a comprehensive way for the better understanding of the overall market. To effectively gather market values, weighted average selling prices have been taken into consideration on the basis of products.

Further, to make this report detail and wide-ranging QY Research has used a top-down approach to evaluate market numbers for almost every category of products. On the other hand, to counter validate all the market estimations, the bottom-up approach has been used by the experts in the medical care industry. While examining different segments of the markets in the medical care industry, the analysts in QY Research have carried out several surveys along with detailed primary research.

Key takeaways from this report

Stakeholders in the medical care industry are following new measures of cost reduction, for example, developing the models of alternative staffing, reduction in supply and administrative cost and shifting patients to outpatient services. Additionally, the key players in the market are also discovering new sources of revenue such as launching new companies, capitalization of intellectual property and commercializing their foreign assets.

QY Research founded in 2007, focuses on IPO and management consulting, chain research of various industries and seminar services and database. The company has its own primary databases such as Industry Association Database, customs export and import database, database of national bureau of statistics and resource from industry experts who have more than ten years’ experience of associating with Research & development industries of consumer goods, energy, Internet and Communication, automotive, medical, and chemicals. QY Research has so far served many Fortune 500 companies. 

List of Tables and Figures

 

Table Sexual Dysfunction Drugs Key Market Segments

Table Key Players Sexual Dysfunction Drugs Covered

Table Global Sexual Dysfunction Drugs Market Size Growth Rate by Type 2013-2025 (Million US$)

Figure Global Sexual Dysfunction Drugs Market Size Market Share by Type 2013-2025

Figure Oral Therapy Figures

Table Key Players of Oral Therapy

Figure Intracavernosal Therapy Figures

Table Key Players of Intracavernosal Therapy

Figure Hormonal Therapy Figures

Table Key Players of Hormonal Therapy

Figure Transurethral Therapy Figures

Table Key Players of Transurethral Therapy

Table Global Sexual Dysfunction Drugs Market Size Growth by Application 2013-2025 (Million US$)

Figure Male Case Studies

Figure Female Case Studies

Figure Sexual Dysfunction Drugs Report Years Considered

Table Global Sexual Dysfunction Drugs Market Size 2013-2025 (Million US$)

Figure Global Sexual Dysfunction Drugs Market Size and Growth Rate 2013-2025 (Million US$)

Table Global Sexual Dysfunction Drugs Market Size by Regions 2013-2025 (Million US$)

Table Global Sexual Dysfunction Drugs Market Size by Regions 2013-2018 (Million US$)

Table Global Sexual Dysfunction Drugs Market Share by Regions 2013-2018

Figure Global Sexual Dysfunction Drugs Market Share by Regions 2013-2018

Figure Global Sexual Dysfunction Drugs Market Share by Regions 2018

Table Market Top Trends

Table Global Sexual Dysfunction Drugs Revenue by Manufacturers (2013-2018) (Million US$)

Table Global Sexual Dysfunction Drugs Market Share by Manufacturers (2013-2018)

Figure Global Sexual Dysfunction Drugs Market Share by Manufacturers in 2018

Table Global Sexual Dysfunction Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)

Table Key Players Head office and Area Served

Table Key Players Sexual Dysfunction Drugs Product/Solution/Service

Table Date of Enter into Sexual Dysfunction Drugs Market

Table Mergers & Acquisitions, Expansion Plans

Table Global Sexual Dysfunction Drugs Market Size by Type (2013-2018) (Million US$)

Table Global Sexual Dysfunction Drugs Market Size Share by Type (2013-2018)

Figure Global Sexual Dysfunction Drugs Market Size Market Share by Type (2013-2018)

Table Global Sexual Dysfunction Drugs Market Size by Application (2013-2018) (Million US$)

Table Global Sexual Dysfunction Drugs Market Size Share by Application (2013-2018)

Figure Global Sexual Dysfunction Drugs Market Size Market Share by Application (2013-2018)

Figure Global Sexual Dysfunction Drugs Revenue Market Share by Application in 2017

Figure United States Sexual Dysfunction Drugs Market Size 2013-2018 (Million US$)

Table United States Key Players Sexual Dysfunction Drugs Revenue (2017-2018) (Million US$)

Table United States Key Players Sexual Dysfunction Drugs Market Share (2017-2018)

Table United States Sexual Dysfunction Drugs Market Size by Type (2013-2018) (Million US$)

Table United States Sexual Dysfunction Drugs Market Share by Type (2013-2018)

Table United States Sexual Dysfunction Drugs Market Size by Application (2013-2018) (Million US$)

Table United States Sexual Dysfunction Drugs Market Share by Application (2013-2018)

Figure Europe Sexual Dysfunction Drugs Market Size 2013-2018 (Million US$)

Table Europe Key Players Sexual Dysfunction Drugs Revenue (2017-2018) (Million US$)

Table Europe Key Players Sexual Dysfunction Drugs Market Share (2017-2018)

Table Europe Sexual Dysfunction Drugs Market Size by Type (2013-2018) (Million US$)

Table Europe Sexual Dysfunction Drugs Market Share by Type (2013-2018)

Table Europe Sexual Dysfunction Drugs Market Size by Application (2013-2018) (Million US$)

Table Europe Sexual Dysfunction Drugs Market Share by Application (2013-2018)

Figure China Sexual Dysfunction Drugs Market Size 2013-2018 (Million US$)

Table China Key Players Sexual Dysfunction Drugs Revenue (2017-2018) (Million US$)

Table China Key Players Sexual Dysfunction Drugs Market Share (2017-2018)

Table China Sexual Dysfunction Drugs Market Size by Type (2013-2018) (Million US$)

Table China Sexual Dysfunction Drugs Market Share by Type (2013-2018)

Table China Sexual Dysfunction Drugs Market Size by Application (2013-2018) (Million US$)

Table China Sexual Dysfunction Drugs Market Share by Application (2013-2018)

Figure Japan Sexual Dysfunction Drugs Market Size 2013-2018 (Million US$)

Table Japan Key Players Sexual Dysfunction Drugs Revenue (2017-2018) (Million US$)

Table Japan Key Players Sexual Dysfunction Drugs Market Share (2017-2018)

Table Japan Sexual Dysfunction Drugs Market Size by Type (2013-2018) (Million US$)

Table Japan Sexual Dysfunction Drugs Market Share by Type (2013-2018)

Table Japan Sexual Dysfunction Drugs Market Size by Application (2013-2018) (Million US$)

Table Japan Sexual Dysfunction Drugs Market Share by Application (2013-2018)

Figure Southeast Asia Sexual Dysfunction Drugs Market Size 2013-2018 (Million US$)

Table Southeast Asia Key Players Sexual Dysfunction Drugs Revenue (2017-2018) (Million US$)

Table Southeast Asia Key Players Sexual Dysfunction Drugs Market Share (2017-2018)

Table Southeast Asia Sexual Dysfunction Drugs Market Size by Type (2013-2018) (Million US$)

Table Southeast Asia Sexual Dysfunction Drugs Market Share by Type (2013-2018)

Table Southeast Asia Sexual Dysfunction Drugs Market Size by Application (2013-2018) (Million US$)

Table Southeast Asia Sexual Dysfunction Drugs Market Share by Application (2013-2018)

Figure India Sexual Dysfunction Drugs Market Size 2013-2018 (Million US$)

Table India Key Players Sexual Dysfunction Drugs Revenue (2017-2018) (Million US$)

Table India Key Players Sexual Dysfunction Drugs Market Share (2017-2018)

Table India Sexual Dysfunction Drugs Market Size by Type (2013-2018) (Million US$)

Table India Sexual Dysfunction Drugs Market Share by Type (2013-2018)

Table India Sexual Dysfunction Drugs Market Size by Application (2013-2018) (Million US$)

Table India Sexual Dysfunction Drugs Market Share by Application (2013-2018)

Figure Central & South America Sexual Dysfunction Drugs Market Size 2013-2018 (Million US$)

Table Central & South America Key Players Sexual Dysfunction Drugs Revenue (2017-2018) (Million US$)

Table Central & South America Key Players Sexual Dysfunction Drugs Market Share (2017-2018)

Table Central & South America Sexual Dysfunction Drugs Market Size by Type (2013-2018) (Million US$)

Table Central & South America Sexual Dysfunction Drugs Market Share by Type (2013-2018)

Table Central & South America Sexual Dysfunction Drugs Market Size by Application (2013-2018) (Million US$)

Table Central & South America Sexual Dysfunction Drugs Market Share by Application (2013-2018)

Table Pfizer Company Details

Table Pfizer Revenue in Sexual Dysfunction Drugs Business (2013-2018) (Million US$)

Figure Pfizer Revenue Growth Rate in Sexual Dysfunction Drugs Business (2013-2018)

Table Pfizer Recent Development

Table GlaxoSmithKline Company Details

Table GlaxoSmithKline Revenue in Sexual Dysfunction Drugs Business (2013-2018)(Million US$)

Figure GlaxoSmithKline Revenue Growth Rate in Sexual Dysfunction Drugs Business (2013-2018)

Table GlaxoSmithKline Recent Development

Table Merck Company Details

Table Merck Revenue in Sexual Dysfunction Drugs Business (2013-2018)(Million US$)

Figure Merck Revenue Growth Rate in Sexual Dysfunction Drugs Business (2013-2018)

Table Merck Recent Development

Table Eli Lilly Company Details

Table Eli Lilly Revenue in Sexual Dysfunction Drugs Business (2013-2018)(Million US$)

Figure Eli Lilly Revenue Growth Rate in Sexual Dysfunction Drugs Business (2013-2018)

Table Eli Lilly Recent Development

Table AbbVie Company Details

Table AbbVie Revenue in Sexual Dysfunction Drugs Business (2013-2018)(Million US$)

Figure AbbVie Revenue Growth Rate in Sexual Dysfunction Drugs Business (2013-2018)

Table AbbVie Recent Development

Table Bayer Company Details

Table Bayer Revenue in Sexual Dysfunction Drugs Business (2013-2018)(Million US$)

Figure Bayer Revenue Growth Rate in Sexual Dysfunction Drugs Business (2013-2018)

Table Bayer Recent Development

Table Teva Pharmaceutical Industries Company Details

Table Teva Pharmaceutical Industries Revenue in Sexual Dysfunction Drugs Business (2013-2018)(Million US$)

Figure Teva Pharmaceutical Industries Revenue Growth Rate in Sexual Dysfunction Drugs Business (2013-2018)

Table Teva Pharmaceutical Industries Recent Development

Table Takeda Company Details

Table Takeda Revenue in Sexual Dysfunction Drugs Business (2013-2018)(Million US$)

Figure Takeda Revenue Growth Rate in Sexual Dysfunction Drugs Business (2013-2018)

Table Takeda Recent Development

Table Apricus Biosciences Company Details

Table Apricus Biosciences Revenue in Sexual Dysfunction Drugs Business (2013-2018)(Million US$)

Figure Apricus Biosciences Revenue Growth Rate in Sexual Dysfunction Drugs Business (2013-2018)

Table Apricus Biosciences Recent Development

Table Emotional Brain Company Details

Table Emotional Brain Revenue in Sexual Dysfunction Drugs Business (2013-2018)(Million US$)

Figure Emotional Brain Revenue Growth Rate in Sexual Dysfunction Drugs Business (2013-2018)

Table Emotional Brain Recent Development

Table Ivix LLX Company Details

Table Leadiant Biosciences Company Details

Table NexMed Company Details

Table S1 Biopharma Company Details

Table Vietstar Biomedical Research Company Details

Table Global Sexual Dysfunction Drugs Market Size by Regions (Million US$) 2018-2025

Figure Global Sexual Dysfunction Drugs Market Size Share by Regions (2018-2025)

Figure Global Sexual Dysfunction Drugs Market Size Share by Regions in 2025

Figure United States Sexual Dysfunction Drugs Market Size Forecast (2018-2025)(Million USD)

Figure Europe Sexual Dysfunction Drugs Market Size Forecast (2018-2025)(Million USD)

Figure China Sexual Dysfunction Drugs Market Size Forecast (2018-2025)(Million USD)

Figure Japan Sexual Dysfunction Drugs Market Size Forecast (2018-2025)(Million USD)

Figure Southeast Asia Sexual Dysfunction Drugs Market Size Forecast (2018-2025)(Million USD)

Figure India Sexual Dysfunction Drugs Market Size Forecast (2018-2025)(Million USD)

Figure Central & South America Sexual Dysfunction Drugs Market Size Forecast (2018-2025)(Million USD)

Table Global Sexual Dysfunction Drugs Market Size by Product (2018-2025) (Million US$)

Figure Global Sexual Dysfunction Drugs Market Size by Product (2018-2025)

Figure Global Sexual Dysfunction Drugs Market Size by Product in 2025

Table Global Sexual Dysfunction Drugs Market Size by Application (2018-2025) (Million US$)

Figure Global Sexual Dysfunction Drugs Market Size by Application (2018-2025)

Figure Global Sexual Dysfunction Drugs Market Size by Application in 2025

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

SELECT A FORMAT
Added to Cart

Electronic (PDF)
$3900
This license allows only one user to access the PDF.

Electronic (PDF)
$7800
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
Samsung SD

RELATED REPORTS

Global and United States Prenatal Education Instrument Market Insights Forecast to 2027
Global and United States Prenatal Education Instrument Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-7D3408
Thu Sep 23 00:00:00 UTC 2021

Add to Cart

Global and China Maternity Color Ultrasound Diagnostic Equipment Market Insights Forecast to 2027
Global and China Maternity Color Ultrasound Diagnostic Equipment Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-10R3375
Thu Sep 23 00:00:00 UTC 2021

Add to Cart

Global and China Pregnant Women Underwear Market Insights Forecast to 2027
Global and China Pregnant Women Underwear Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-10E3374
Thu Sep 23 00:00:00 UTC 2021

Add to Cart

Global and United States Cervical Biopsy Forceps Market Insights Forecast to 2027
Global and United States Cervical Biopsy Forceps Market Insights, Forecast to 2027

120 Pages
Type: Report
Code: QYRE-Auto-31G6614
Tue Sep 21 00:00:00 UTC 2021

Add to Cart